Severe Sinus Congestion And Pain Tablet, Coated
NDC Package 83059-0121-6
Package Information
Severe Sinus Congestion And Pain (acetaminophen, guaifenesin, phenylephrine) tablets is do not take more than directed (see OVERDOSE WARNING)adults and children 12 years and over• take 2 caplets every 4 hours • swallow whole; do not crush, chew or dissolve • do not take more than 10 caplets in 24 hours children under 12 yearsask a doctor. This formulation utilizes a tablet, coated delivery system. Marketed by Shield Pharmaceuticals Corp, this product is identified by NDC 83059-0121 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1243679 - acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet
- RxCUI: 1243679 - acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet
- RxCUI: 1243679 - APAP 325 MG / GG 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet
- RxCUI: 1243679 - APAP 325 MG / Guaifenesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 83059 - Shield Pharmaceuticals Corp
- 83059-0121 - Severe Sinus Congestion And Pain
- 83059-0121-6 - 60 TABLET, COATED in 1 BOTTLE
- 83059-0121 - Severe Sinus Congestion And Pain
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83059-0121-6 identifies a specific commercial package of 60 tablet, coated in 1 bottle of Severe Sinus Congestion And Pain, a human over the counter drug labeled by Shield Pharmaceuticals Corp. This tablet, coated is formulated for oral use and contains acetaminophen; guaifenesin; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Shield Pharmaceuticals Corp on December 05, 2025. The current certification is valid through December 31, 2026.
How is this Shield Pharmaceuticals Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83059012106. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.